Correlation between hyperthermoradiosensitivity and clinical effect in carcinoma of the esophagus

S. Ohno, M. Morita, S. Tsutsui, H. Matsuura, H. Kuwano, Y. Maehara, K. Sugimachi

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The correlation between hyperthermoradiosensitivity evaluated by an in vitro succinate dehydrogenase inhibition (SDI) test and the histopathologic effects of hyperthermochemoradiotherapy (HCR therapy) were investigated in 43 patients with carcinoma of the esophagus. The succinate dehydrogenase (SD) activity of tissue fragments taken at biopsy was assayed after exposure to heat (43 degrees C.) and radiation (6 grays) was done. The sensitivity to radiation plus heat treatment was estimated by the percentage of SD activity of the treated cells, compared with that of the control cells. The 43 patients were divided into three groups according to the degree of SD activity after exposure to radiation plus heat treatment. The SD activity was less than 50 per cent in group 1 (highly sensitive), between 50 and 70 per cent in group 2 (moderately sensitive), more than 70 per cent in group 3 (less sensitive). Eighteen of 20 in group 1, 11 of 17 in group 2 and two of six in group 3 were classified as being histopathologically 'effective' for HCR therapy. The two year survival rate for groups 1, 2 and 3 were 55.5, 34.9 and zero per cent, respectively, while there were no statistical differences with regard to prognostic factors. These data suggest that in vitro activities of SD correlate well with the clinical effectiveness of HCR therapy. Therefore, it is recommended that a SD inhibition test be included among the guidelines for clinical management.

Original languageEnglish
Pages (from-to)472-476
Number of pages5
JournalSurgery Gynecology and Obstetrics
Volume171
Issue number6
Publication statusPublished - Dec 1 1990

Fingerprint

Succinate Dehydrogenase
Esophagus
Carcinoma
Hot Temperature
Radiation Tolerance
Survival Rate
Guidelines
Radiation
Biopsy
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery
  • Obstetrics and Gynaecology

Cite this

Ohno, S., Morita, M., Tsutsui, S., Matsuura, H., Kuwano, H., Maehara, Y., & Sugimachi, K. (1990). Correlation between hyperthermoradiosensitivity and clinical effect in carcinoma of the esophagus. Surgery Gynecology and Obstetrics, 171(6), 472-476.

Correlation between hyperthermoradiosensitivity and clinical effect in carcinoma of the esophagus. / Ohno, S.; Morita, M.; Tsutsui, S.; Matsuura, H.; Kuwano, H.; Maehara, Y.; Sugimachi, K.

In: Surgery Gynecology and Obstetrics, Vol. 171, No. 6, 01.12.1990, p. 472-476.

Research output: Contribution to journalArticle

Ohno, S, Morita, M, Tsutsui, S, Matsuura, H, Kuwano, H, Maehara, Y & Sugimachi, K 1990, 'Correlation between hyperthermoradiosensitivity and clinical effect in carcinoma of the esophagus', Surgery Gynecology and Obstetrics, vol. 171, no. 6, pp. 472-476.
Ohno S, Morita M, Tsutsui S, Matsuura H, Kuwano H, Maehara Y et al. Correlation between hyperthermoradiosensitivity and clinical effect in carcinoma of the esophagus. Surgery Gynecology and Obstetrics. 1990 Dec 1;171(6):472-476.
Ohno, S. ; Morita, M. ; Tsutsui, S. ; Matsuura, H. ; Kuwano, H. ; Maehara, Y. ; Sugimachi, K. / Correlation between hyperthermoradiosensitivity and clinical effect in carcinoma of the esophagus. In: Surgery Gynecology and Obstetrics. 1990 ; Vol. 171, No. 6. pp. 472-476.
@article{4b13b3fc8f4f49a3a0c363c6d0c8a4c3,
title = "Correlation between hyperthermoradiosensitivity and clinical effect in carcinoma of the esophagus",
abstract = "The correlation between hyperthermoradiosensitivity evaluated by an in vitro succinate dehydrogenase inhibition (SDI) test and the histopathologic effects of hyperthermochemoradiotherapy (HCR therapy) were investigated in 43 patients with carcinoma of the esophagus. The succinate dehydrogenase (SD) activity of tissue fragments taken at biopsy was assayed after exposure to heat (43 degrees C.) and radiation (6 grays) was done. The sensitivity to radiation plus heat treatment was estimated by the percentage of SD activity of the treated cells, compared with that of the control cells. The 43 patients were divided into three groups according to the degree of SD activity after exposure to radiation plus heat treatment. The SD activity was less than 50 per cent in group 1 (highly sensitive), between 50 and 70 per cent in group 2 (moderately sensitive), more than 70 per cent in group 3 (less sensitive). Eighteen of 20 in group 1, 11 of 17 in group 2 and two of six in group 3 were classified as being histopathologically 'effective' for HCR therapy. The two year survival rate for groups 1, 2 and 3 were 55.5, 34.9 and zero per cent, respectively, while there were no statistical differences with regard to prognostic factors. These data suggest that in vitro activities of SD correlate well with the clinical effectiveness of HCR therapy. Therefore, it is recommended that a SD inhibition test be included among the guidelines for clinical management.",
author = "S. Ohno and M. Morita and S. Tsutsui and H. Matsuura and H. Kuwano and Y. Maehara and K. Sugimachi",
year = "1990",
month = "12",
day = "1",
language = "English",
volume = "171",
pages = "472--476",
journal = "Journal of the American College of Surgeons",
issn = "1072-7515",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Correlation between hyperthermoradiosensitivity and clinical effect in carcinoma of the esophagus

AU - Ohno, S.

AU - Morita, M.

AU - Tsutsui, S.

AU - Matsuura, H.

AU - Kuwano, H.

AU - Maehara, Y.

AU - Sugimachi, K.

PY - 1990/12/1

Y1 - 1990/12/1

N2 - The correlation between hyperthermoradiosensitivity evaluated by an in vitro succinate dehydrogenase inhibition (SDI) test and the histopathologic effects of hyperthermochemoradiotherapy (HCR therapy) were investigated in 43 patients with carcinoma of the esophagus. The succinate dehydrogenase (SD) activity of tissue fragments taken at biopsy was assayed after exposure to heat (43 degrees C.) and radiation (6 grays) was done. The sensitivity to radiation plus heat treatment was estimated by the percentage of SD activity of the treated cells, compared with that of the control cells. The 43 patients were divided into three groups according to the degree of SD activity after exposure to radiation plus heat treatment. The SD activity was less than 50 per cent in group 1 (highly sensitive), between 50 and 70 per cent in group 2 (moderately sensitive), more than 70 per cent in group 3 (less sensitive). Eighteen of 20 in group 1, 11 of 17 in group 2 and two of six in group 3 were classified as being histopathologically 'effective' for HCR therapy. The two year survival rate for groups 1, 2 and 3 were 55.5, 34.9 and zero per cent, respectively, while there were no statistical differences with regard to prognostic factors. These data suggest that in vitro activities of SD correlate well with the clinical effectiveness of HCR therapy. Therefore, it is recommended that a SD inhibition test be included among the guidelines for clinical management.

AB - The correlation between hyperthermoradiosensitivity evaluated by an in vitro succinate dehydrogenase inhibition (SDI) test and the histopathologic effects of hyperthermochemoradiotherapy (HCR therapy) were investigated in 43 patients with carcinoma of the esophagus. The succinate dehydrogenase (SD) activity of tissue fragments taken at biopsy was assayed after exposure to heat (43 degrees C.) and radiation (6 grays) was done. The sensitivity to radiation plus heat treatment was estimated by the percentage of SD activity of the treated cells, compared with that of the control cells. The 43 patients were divided into three groups according to the degree of SD activity after exposure to radiation plus heat treatment. The SD activity was less than 50 per cent in group 1 (highly sensitive), between 50 and 70 per cent in group 2 (moderately sensitive), more than 70 per cent in group 3 (less sensitive). Eighteen of 20 in group 1, 11 of 17 in group 2 and two of six in group 3 were classified as being histopathologically 'effective' for HCR therapy. The two year survival rate for groups 1, 2 and 3 were 55.5, 34.9 and zero per cent, respectively, while there were no statistical differences with regard to prognostic factors. These data suggest that in vitro activities of SD correlate well with the clinical effectiveness of HCR therapy. Therefore, it is recommended that a SD inhibition test be included among the guidelines for clinical management.

UR - http://www.scopus.com/inward/record.url?scp=0025563298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025563298&partnerID=8YFLogxK

M3 - Article

C2 - 2244279

AN - SCOPUS:0025563298

VL - 171

SP - 472

EP - 476

JO - Journal of the American College of Surgeons

JF - Journal of the American College of Surgeons

SN - 1072-7515

IS - 6

ER -